Humana Inc. $HUM Holdings Decreased by Westwind Capital

Westwind Capital lowered its position in Humana Inc. (NYSE:HUM) by 4.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,266 shares of the insurance provider’s stock after selling 1,391 shares during the quarter. Humana makes up approximately 2.6% of Westwind Capital’s portfolio, making the stock its 12th biggest position. Westwind Capital’s holdings in Humana were worth $10,785,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Manning & Napier Advisors LLC bought a new stake in Humana in the second quarter worth $1,412,000. The Manufacturers Life Insurance Company boosted its holdings in Humana by 10.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 70,185 shares of the insurance provider’s stock valued at $27,879,000 after acquiring an additional 6,690 shares during the period. Sustainable Insight Capital Management LLC grew its position in Humana by 23.7% during the 4th quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock worth $6,341,000 after acquiring an additional 4,740 shares during the last quarter. Vista Investment Partners LLC bought a new stake in Humana in the third quarter valued at approximately $3,254,000. Finally, Pzena Investment Management LLC purchased a new stake in shares of Humana during the second quarter valued at approximately $1,749,014,000. 92.38% of the stock is currently owned by institutional investors.

Humana Stock Down 2.2%

Humana stock traded down $8.83 on Thursday, hitting $387.68. 2,651,655 shares of the stock traded hands, compared to its average volume of 1,649,764. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $428.88. The firm has a market cap of $46.55 billion, a P/E ratio of 36.68, a price-to-earnings-growth ratio of 2.49 and a beta of 0.74. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. The business’s fifty day simple moving average is $387.26 and its 200 day simple moving average is $332.87.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. During the same period last year, the business earned $6.27 EPS. Humana’s quarterly revenue was up 26.2% compared to the same quarter last year. As a group, sell-side analysts forecast that Humana Inc. will post 9.01 earnings per share for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 27th. Investors of record on Friday, October 30th will be paid a $0.8850 dividend. The ex-dividend date is Friday, October 30th. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. Humana’s dividend payout ratio is presently 33.49%.

Humana News Summary

Here are the key news stories impacting Humana this week:

• Positive Sentiment: Humana’s improved 2027 Medicare Advantage Star Ratings reduced concerns about the company’s future bonus payments and plan profitability, prompting a sharp post-market rally. Humana surges post-market on boost in 2027 Medicare Advantage star ratings
• Positive Sentiment: Cantor Fitzgerald upgraded HUM from “Neutral” to “Overweight” and raised its price target to $460 from $300, reinforcing the bullish reaction to the ratings news. Humana stock rating raised to Overweight at Cantor Fitzgerald
• Positive Sentiment: The ratings outcome provides support for the recent investment thesis that Humana’s Medicare Advantage margins and operating performance could improve.
• Neutral Sentiment: Humana is scheduled to release its third-quarter 2026 interim results, giving investors another upcoming test of medical-cost trends and Medicare Advantage profitability. Humana sets date for third-quarter 2026 interim report
• Negative Sentiment: Before the CMS release, shares had pulled back as investors reduced exposure or took profits ahead of the ratings announcement. The move highlighted the stock’s sensitivity to Star Rating expectations, while the elevated valuation leaves room for volatility if future ratings or medical-cost results disappoint. Why Humana stock is falling today

Analyst Ratings Changes

A number of equities research analysts recently commented on HUM shares. HSBC lowered shares of Humana to a “hold” rating in a report on Thursday, July 30th. Wolfe Research restated an “outperform” rating and set a $450.00 price target on shares of Humana in a report on Monday, August 24th. Cantor Fitzgerald upgraded Humana from a “neutral” rating to an “overweight” rating and increased their price objective for the stock from $300.00 to $460.00 in a report on Wednesday. Truist Financial lifted their price objective on Humana from $320.00 to $415.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. Finally, Wall Street Zen cut Humana from a “buy” rating to a “hold” rating in a research note on Sunday, September 27th. Sixteen equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $422.52.

Humana Company Profile

Humana Inc is a health and well-being company headquartered in Louisville, Kentucky. Founded in 1961, the company began as a nursing home operator before expanding into hospitals and health insurance. Today, Humana primarily provides health insurance products and healthcare services for older adults, individuals, military families and other members in the United States.

Humana’s insurance business offers Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid coverage in select markets.